Omega-3 fatty acids inhibit the up-regulation of endothelial chemokines in maintenance hemodialysis patients

Nephrology Dialysis Transplantation

Volumn 30, Issue 2, 2015, Pages 266-274

  Hung, Adriana M ^a,b   Booker, Cindy ^b   Ellis, Charles D ^b   Siew, Edward D ^a,b   Graves, Amy J ^c   Shintani, Ayumi ^c   Abumrad, Naji N ^b   Himmelfarb, Jonathan ^d   Ikizler, Talat Alp ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

end stage renal disease; inflammation; MCP 1; omega 3; RANTES

Indexed keywords

C REACTIVE PROTEIN; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; PLACEBO; PROCALCITONIN; RANTES; AUTACOID; BIOLOGICAL MARKER; CALCITONIN; CHEMOKINE; IL6 PROTEIN, HUMAN; OMEGA 3 FATTY ACID; PROTEIN PRECURSOR;

ADULT; APPENDIX PERFORATION; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GRAFT INFECTION; HEMODIALYSIS; HUMAN; HUMAN CELL; HYPERVOLEMIA; INFLAMMATION; MALE; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SPRAIN; THORAX PAIN; TREATMENT OUTCOME; TREATMENT RESPONSE; UPREGULATION; AGED; BLOOD; DRUG EFFECTS; FEASIBILITY STUDY; METABOLISM; MIDDLE AGED; PILOT STUDY; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR; VASCULAR ENDOTHELIUM;

ADULT; AGED; BIOMARKERS; C-REACTIVE PROTEIN; CALCITONIN; CHEMOKINES; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; EICOSAPENTAENOIC ACID; ENDOTHELIUM, VASCULAR; FATTY ACIDS, OMEGA-3; FEASIBILITY STUDIES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; MIDDLE AGED; PILOT PROJECTS; PROTEIN PRECURSORS; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; UP-REGULATION;

EID: 84922544339     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu283     Document Type: Article

References (29)

1. Collins AJ, Foley RN, Herzog C et al. US Renal Data System 2012 Annual Data Report. Am J Kidney Dis 2013; 61: A7, e1-476
2. Hung A, Pupim L, Yu C et al. Determinants of C-reactive protein in chronic hemodialysis patients: relevance of dialysis catheter utilization. Hemodial Int 2008; 12: 236-243
3. Zimmermann J, Herrlinger S, Pruy A et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55: 648-658
4. De Caterina R. n-3 fatty acids in cardiovascular disease. N Engl J Med 2011; 364: 2439-2450
5. Spencer M, Finlin BS, Unal R et al. Omega-3 fatty acids reduce adipose tissue macrophages in human subjects with insulin resistance. Diabetes 2013; 62: 1709-1717
6. Saifullah A, Watkins BA, Saha C et al. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients-A pilot study. Nephrol Dial Transplant 2007; 22: 3561-3567
7. Perunicic-Pekovic GB, Rasic ZR, Pljesa SI et al. Effect of n-3 fatty acids on nutritional status and inflammatory markers in haemodialysis patients. Nephrology (Carlton) 2007; 12: 331-336
8. Calder PC. Omega 3 polyunsaturated fatty acids, inflammation and immunity. World Rev Nutr Diet 2001; 88: 109-116
9. Balk EM, Lichtenstein AH, Chung M et al. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis 2006; 189: 19-30
10. Zoccali C, Maas R, Cutrupi S et al. Asymmetric dimethyl-Arginine (ADMA) response to inflammation in acute infections. Nephrol Dial Transplant 2007; 22: 801-806
11. Schepers E, Glorieux G, Dhondt A et al. Role of symmetric dimethylarginine in vascular damage by increasing ROS via store-operated calcium influx in monocytes. Nephrol Dial Transplant 2009; 24: 1429-1435
12. Friedman AN. Omega-3 fatty acid supplementation in advanced kidney disease. Semin Dial 2010; 23: 396-400
13. Kutner NG, Clow PW, Zhang R et al. Association of fish intake and survival in a cohort of incident dialysis patients. Am J Kidney Dis 2002; 39: 1018-1024
14. Noori N, Dukkipati R, Kovesdy CP et al. Dietary omega-3 fatty acid, ratio of omega-6 to omega-3 intake, inflammation, and survival in long-Term hemodialysis patients. Am J Kidney Dis 2011; 58: 248-256
15. Lok CE, Moist L, Hemmelgarn BR et al. Effect of fish oil supplementation on graft patency and cardiovascular events among patients with new synthetic arteriovenous hemodialysis grafts: a randomized controlled trial. JAMA 2012; 307: 1809-1816
16. Taccone-Gallucci M, Manca-di-Villahermosa S, Battistini L et al. N-3 PUFAs reduce oxidative stress in ESRD patients on maintenance HD by inhibiting 5-lipoxygenase activity. Kidney Int 2006; 69: 1450-1454
17. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002; 106: 2747-2757
18. Piemonti L, Calori G, Lattuada G et al. Association between plasma monocyte chemoattractant protein-1 concentration and cardiovascular disease mortality in middle-Aged diabetic and nondiabetic individuals. Diabetes Care 2009; 32: 2105-2110
19. Yeun JY, Levine RA, Mantadilok V et al. C-reactive protein predicts allcause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2000; 35: 469-476
20. Gosling J, Slaymaker S, Gu L et al. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest 1999; 103: 773-778
21. Reape TJ, Groot PH. Chemokines and atherosclerosis. Atherosclerosis 1999; 147: 213-225
22. Kavsak PA, Ko DT, Newman AM et al. Risk stratification for heart failure and death in an acute coronary syndrome population using inflammatory cytokines and N-Terminal pro-brain natriuretic peptide. Clin Chem 2007; 53: 2112-2118
23. De Lemos JA, Morrow DA, Blazing MA et al. Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial. J Am Coll Cardiol 2007; 50: 2117-2124
24. Mishra A, Chaudhary A, Sethi S. Oxidized omega-3 fatty acids inhibit NFkappaB activation via a PPARalpha-dependent pathway. Arterioscler Thromb Vasc Biol 2004; 24: 1621-1627
25. Venkatraman J, Meksawan K. Effects of dietary omega3 and omega6 lipids and vitamin E on chemokine levels in autoimmune-prone MRL/MpJ-lpr/lpr mice. J Nutr Biochem 2002; 13: 479
26. Li H, Ruan XZ, Powis SH et al. EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gammadependent mechanism. Kidney Int 2005; 67: 867-874
27. Svensson M, Schmidt EB, Jorgensen KA et al. N-3 fatty acids as secondary prevention against cardiovascular events in patients who undergo chronic hemodialysis: a randomized, placebo-controlled intervention trial. Clin J Am Soc Nephrol 2006; 1: 780-786
28. Friedman AN, Yu Z, Denski C et al. Fatty acids and other risk factors for sudden cardiac death in patients starting hemodialysis. Am J Nephrol 2013; 38: 12-18
29. Svensson M, Frobert O, Schmidt EB et al. The effect of n-3 fatty acids on levels of methylarginines in patients with end-stage renal disease. J Nephrol 2010; 23: 459-464